Posted by Michael Wonder on 15 Feb 2021
Agenda for the March 2021 PBAC meeting
15 February 2021 - A revised agenda for the March 2021 PBAC meeting is now available.
The revised agenda includes a new minor submission for obeticholic acid (Ocaliva).
Obeticholic acid has been considered by the PBAC three times; the first two submissions were rejected; the third submission was deferred in November last year.
Too bad if you are a consumer who would like to submit a comment on this submission to the PBAC; consumer comments for the March 2021 PBAC meeting closed on 10 February.
